Healthcare innovation is evolving rapidly with organoids, nanomedicine, and non-addictive pain therapies leading the way. Organoids enable human-relevant testing, nanoparticles allow precise drug delivery, and new pain treatments reduce dependence risks. Success now requires not just scientific breakthroughs, but strategic orchestration—scalable R&D, regulatory alignment, and societal impact are key to shaping the next era of precision medicine.

Participez à i-Lab 2025 et transformez votre innovation en startup ! Jusqu'à 600 000€ de financement. Candidature avant le 11 mars !